Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

GSK managed to beat analysts’ revenue predictions ... driven once again by its shingles vaccine Shingrix and HIV therapies sold under the ViiV Healthcare joint venture. Shingrix grew 19% to ...

Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter ... Killers:' How Memecoins Teach A 'Skill To Succeed' In Crypto Shingrix, a vaccine against herpes zoster (shingles), grew 17% in the full ...

GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a prefilled syringe version of Shingrix, its recombinant zoster vaccine for ...

GSK (GSK) announced that the US Food and Drug Administration, FDA, has accepted for review the regulatory application of a prefilled syringe ...

GSK had initially entered into a collaboration deal, valued at £2.5 billion for three years until 2026, with Zhifei last year to market Shingrix in mainland China.

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...

UK pharmaceutical giant GSK has confirmed that it has signed an agreement to acquire the privately-held biotechnology company ...

US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...

The US Food and Drug Administration (FDA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix, GSK’s recombinant zoster vaccine for the prevention of ...